ACS boots early registration effect

Starting from January 1, 2016 the ACS PharmaProtect GmbH adapts its fee model. The revised model offers a financial incentive for an earlier entry into the securPharm project. In this context, ACS Pharma Protect increases the initial set-up fee (Component A) starting from July 1, 2016. In the fee model the initial set-up fee supports primarily the financing of the investment of the entire system that will ensure the exchange of data for verification of medicinal products within the framework of anti-counterfeiting protection.

The degressively scaled annual operating fee (Component B) as well as the degressively scaled fee per data set / pack volume (Component C) help to finance the operating costs. The case studies demonstrate the fees of four different companies, which distinguish on the number of, by the respective pharmaceutical companies in the database system of the pharmaceutical industry, provided packs.

In addition to gain valuable experiences for the mandatory real-time operations and to test your systems for counterfeit protection, the fee model offers now a financial incentive for the early entry. Currently more than 30 pharmaceutical companies already participate in the securPharm project.

ACS PharmaProtect GmbH is at your disposal for further questions or specific model calculations for you company.

ACS PharmaProtect GmbH
Taubenstrasse 20
10117 Berlin
Tel +49 30 577 037 900
Fax +49 30 577 037 909

Mr. Tobias Beer (Project development & Contract management)
Mrs. Antje Gerlach (Project coordination)

Go back